logo

For the Inventor, By the Inventor

Versailles, France

Jean-Paul Fournier

This inventor holds 13 USPTO granted patents. Top assignees: Choay, S.a., Dropic - Societe Civile De Gestion De Droits De Propriete Industrielle, Sanofi. Active years: 1979-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Paul Fournier. Retrieved from https://idiyas.com/inventor/jean-paul-fournier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Versailles, FR (1980 - 1990)
  • Paris, FR (1979 - 1991)

Company Filing History:

goldMedal5 out of 49 
 
Choay, S.a.
 patents
silverMedal3 out of 4 
 
Dropic - Societe Civile De Gestion De Droits De Propriete Industrielle
 patents
bronzeMedal2 out of 1,547 
 
Sanofi
 patents
4. 2 out of 44 
 
Sanofi Sa
 patents
5. 1 out of 834,570 
Other
 patents

Years Active: 1979-1991

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4983726 - Process for preparing nitrosourea derivatives (1991-01-08),
2. 4980349 - Sulphonamides derived from diarylmethanes, the processes for preparing (1990-12-25),
3. 4902791 - Nitrosourea derivatives, process for their preparation and medicaments (1990-02-20),
4. 4883903 - Novel procedure for the preparation of activated nitrosocarbamates (1989-11-28),
5. 4871843 - Cyclic benzenesulfonamides, process for their preparation and their use (1989-10-03),
6. 4760062 - Pharmaceutical compositions of N-heterocyclic benzenesulfonamides and (1988-07-26),
7. 4714700 - N-substituted 2,4-dialkoxy benzenesulfonamides and pharmaceutical (1987-12-22),
8. 4618459 - Substituted 2,4-dialkoxy benzene sulfonyl chlorides (1986-10-21),
9. 4585769 - Benzenesulfonyl-lactams and their use as active substances of (1986-04-29),
10. 4457875 - Substituted 2,4 dialkoxy benzene sulfonyl chlorides (1984-07-03),
11. 4225611 - Novel n-substituted benzenesulfonamide, process for its preparation and (1980-09-30),
12. 4211776 - N-Substituted 2-methoxybenzenesulphonamides, process for preparing them (1980-07-08),
13. 4132786 - N-Substituted 2-methoxybenzenesulphonamides and medicaments containing (1979-01-02),

Title: The Innovative Contributions of Jean-Paul Fournier

Introduction

Jean-Paul Fournier is a notable inventor based in Versailles, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on nitrosourea derivatives. With a total of 13 patents to his name, Fournier's inventions have the potential to impact cancer treatment and other medical applications.

Latest Patents

One of Fournier's latest patents is a process for preparing nitrosourea derivatives. This invention relates to the synthesis of nitrosourea derivatives and pharmaceutical compositions containing them. The compounds he has developed exhibit antitumor activity, which could be crucial in the fight against cancer. The specific formula for these derivatives includes various groups that can represent hydrogen atoms or alkyl groups, showcasing the complexity and potential of his work.

Career Highlights

Throughout his career, Fournier has worked with several prominent companies, including Choay and Dropic - Société Civile De Gestion De Droits De Propriété Industrielle. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Fournier has collaborated with notable individuals in his field, including Patrick Choay and Pierre M Roger. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Jean-Paul Fournier's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work on nitrosourea derivatives demonstrates the potential for innovation in cancer treatment and showcases the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…